Literature DB >> 6091217

Endorphins and exercise.

V J Harber, J R Sutton.   

Abstract

The endogenous opioids seem likely to be assigned a significant role in the integrated hormonal and metabolic response to exercise. This article reviews the present evidence on exercise and the endogenous opioids, and examines their involvement in a number of widely disparate physiological processes. In considering the role of individual opioid peptides, it is important to remember that many of the tools and techniques now used are still relatively crude. Most studies have demonstrated that serum concentrations of endogenous opioids, in particular beta-endorphin and beta-lipotrophin, increase in response to both acute exercise and training programmes. Elevated serum beta-endorphin concentrations induced by exercise have been linked to several psychological and physiological changes, including mood state changes and 'exercise-induced euphoria', altered pain perception, menstrual disturbances in female athletes, and the stress responses of numerous hormones (growth hormone, ACTH, prolactin, catecholamines and cortisol). Many reports have described a role for the endorphin response as seen during exercise and have used the opioid receptor antagonist, naloxone, to investigate and verify the degree of involvement of the opioids. However, whether the observed increases in peripheral endorphin concentrations are sufficient to cause immediate mood changes, create menstrual cycle dysfunction or alter pain perception is still not resolved. A relatively new implication for the endorphins and associated changes with exercise is in ventilatory regulation. A number of studies have suggested that endogenous opioids depress ventilation and may, therefore, play a role in ventilatory regulation by carbon dioxide, hypoxia and exercise. It may also be possible that during exercise, the perception of fatigue is modulated by an increase of endogenous opioids.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6091217     DOI: 10.2165/00007256-198401020-00004

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  84 in total

1.  Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine.

Authors:  J Hughes
Journal:  Brain Res       Date:  1975-05-02       Impact factor: 3.252

2.  Naloxone increases ACTH and cortisol levels in man.

Authors:  J Volavka; D Cho; A Mallya; J Bauman
Journal:  N Engl J Med       Date:  1979-05-03       Impact factor: 91.245

3.  Dynorphin-(1-13), an extraordinarily potent opioid peptide.

Authors:  A Goldstein; S Tachibana; L I Lowney; M Hunkapiller; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

4.  Phylogenetic distribution of a morphine-like peptide 'enkephalin'.

Authors:  R Simantov; R Goodman; D Aposhian; S H Snyder
Journal:  Brain Res       Date:  1976-07-23       Impact factor: 3.252

5.  Exercise and the endogenous opioids.

Authors: 
Journal:  N Engl J Med       Date:  1981-12-24       Impact factor: 91.245

6.  Changes in pituitary hormone levels induced by met-enkephalin in man--the role of dopamine.

Authors:  G Delitala; A Grossman; G M Besser
Journal:  Life Sci       Date:  1981-10-12       Impact factor: 5.037

7.  The role of opioid peptides in the hormonal responses to acute exercise in man.

Authors:  A Grossman; P Bouloux; P Price; P L Drury; K S Lam; T Turner; J Thomas; G M Besser; J Sutton
Journal:  Clin Sci (Lond)       Date:  1984-11       Impact factor: 6.124

8.  Endorphins and the regulations of the human menstrual cycle.

Authors:  J Blankstein; F I Reyes; J S Winter; C Faiman
Journal:  Clin Endocrinol (Oxf)       Date:  1981-03       Impact factor: 3.478

9.  The role of endogenous opiates in LH secretion during the menstrual cycle.

Authors:  M E Quigley; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1980-07       Impact factor: 5.958

10.  Profound analgesic effects of beta-endorphin in man.

Authors:  T Oyama; T Jin; R Yamaya; N Ling; R Guillemin
Journal:  Lancet       Date:  1980-01-19       Impact factor: 79.321

View more
  28 in total

1.  Mood and selective attention in the cold: the effect of interval versus continuous exercise.

Authors:  Matthew D Muller; Sarah M Muller; Chul-Ho Kim; Edward J Ryan; John Gunstad; Ellen L Glickman
Journal:  Eur J Appl Physiol       Date:  2010-12-09       Impact factor: 3.078

Review 2.  Opioids and exercise. An update.

Authors:  G A Sforzo
Journal:  Sports Med       Date:  1989-02       Impact factor: 11.136

Review 3.  The psychological benefits of exercise and the treatment of delinquent adolescents.

Authors:  J R MacMahon
Journal:  Sports Med       Date:  1990-06       Impact factor: 11.136

4.  Plasma levels of beta-endorphin, prolactin and gonadotropins in male athletes after an international nordic ski race.

Authors:  C Mougin; M T Henriet; A Baulay; D Haton; S Berthelay; R C Gaillard
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1988

5.  Anorexia nervosa and exercise. Implications from recent findings.

Authors:  J A Blumenthal; S Rose; J L Chang
Journal:  Sports Med       Date:  1985 Jul-Aug       Impact factor: 11.136

Review 6.  Hormonal alterations due to exercise.

Authors:  J C Bunt
Journal:  Sports Med       Date:  1986 Sep-Oct       Impact factor: 11.136

7.  Functional dyspepsia is associated with lower exercise levels: A population-based study.

Authors:  Natasha A Koloski; Michael Jones; Marjorie M Walker; Gerald Holtmann; Nicholas J Talley
Journal:  United European Gastroenterol J       Date:  2020-03-30       Impact factor: 4.623

Review 8.  Is the gut an athletic organ? Digestion, absorption and exercise.

Authors:  F Brouns; E Beckers
Journal:  Sports Med       Date:  1993-04       Impact factor: 11.136

Review 9.  The regular menstrual cycle and athletic performance.

Authors:  R G Eston
Journal:  Sports Med       Date:  1984 Nov-Dec       Impact factor: 11.136

Review 10.  Factors influencing the exercise behaviour of patients.

Authors:  R J Shephard
Journal:  Sports Med       Date:  1985 Sep-Oct       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.